DK0614362T3 - Farmaceutiske præparater på basis af ebastin og dermed analoge forbindelser - Google Patents

Farmaceutiske præparater på basis af ebastin og dermed analoge forbindelser

Info

Publication number
DK0614362T3
DK0614362T3 DK93901804.0T DK93901804T DK0614362T3 DK 0614362 T3 DK0614362 T3 DK 0614362T3 DK 93901804 T DK93901804 T DK 93901804T DK 0614362 T3 DK0614362 T3 DK 0614362T3
Authority
DK
Denmark
Prior art keywords
pct
ebastine
pharmaceutical preparations
analogous compounds
preparations based
Prior art date
Application number
DK93901804.0T
Other languages
English (en)
Other versions
DK0614362T5 (da
Inventor
Michel Veillard
Jean-Marc Bobee
Guillaume Conrath
Gabriel Gousset
Michel Ponsot
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9419600&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0614362(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Application granted granted Critical
Publication of DK0614362T3 publication Critical patent/DK0614362T3/da
Publication of DK0614362T5 publication Critical patent/DK0614362T5/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
DK93901804T 1991-12-03 1992-12-01 Farmaceutiske præparater på basis af ebastin eller dermed analoge forbindelser DK0614362T5 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9114936A FR2684298B1 (fr) 1991-12-03 1991-12-03 Nouvelles compositions pharmaceutiques solides a base de derives de lapiperidine substitues en 1,4.
PCT/FR1992/001116 WO1993010782A1 (fr) 1991-12-03 1992-12-01 Compositions pharmaceutiques a base d'ebastime ou de ses analoques

Publications (2)

Publication Number Publication Date
DK0614362T3 true DK0614362T3 (da) 1997-03-10
DK0614362T5 DK0614362T5 (da) 2008-11-10

Family

ID=9419600

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93901804T DK0614362T5 (da) 1991-12-03 1992-12-01 Farmaceutiske præparater på basis af ebastin eller dermed analoge forbindelser

Country Status (12)

Country Link
US (1) US5460829A (da)
EP (1) EP0614362B1 (da)
JP (1) JP3518601B2 (da)
AT (1) ATE148990T1 (da)
CA (1) CA2123232C (da)
DE (1) DE69217554T2 (da)
DK (1) DK0614362T5 (da)
ES (1) ES2097490T3 (da)
FR (1) FR2684298B1 (da)
GR (1) GR3022615T3 (da)
HK (1) HK1006273A1 (da)
WO (1) WO1993010782A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5717025A (en) * 1996-09-16 1998-02-10 H. B. Fuller Licensing & Financing, Inc. Melamine-formaldehyde resin based adhesive compositions
JP2007246539A (ja) * 1997-10-20 2007-09-27 Dainippon Sumitomo Pharma Co Ltd 速溶性医薬組成物
WO2002100339A2 (en) 2001-06-13 2002-12-19 Biogal Gyogyszergyar Rt. Novel process for preparing rac-bicalutamide and its intermediates
CA2478897A1 (en) * 2002-03-12 2003-09-18 Y's Therapeutics Co., Limited Compounds capable of inhibiting immunocyte-related allergic immune reactions
TWI286942B (en) * 2002-06-10 2007-09-21 Dainippon Sumitomo Pharma Co Rapidly disintegrating tablet and preparing method thereof
US20050008691A1 (en) * 2003-05-14 2005-01-13 Arturo Siles Ortega Bicalutamide compositions
ES2231043B2 (es) * 2004-10-29 2005-10-01 Laboratorios Cinfa, S.A. Composicion farmaceutica de ebastina de liberacion inmediata y su proceso de fabricacion.
DE602005000992D1 (de) * 2005-04-25 2007-06-06 Alter Lab Feste Arzneizubereitung enthaltend ein kristallines in 1,4-Stellungen substituiertes Piperidinderivat
EP1898882B1 (en) * 2005-06-09 2009-10-28 Elan Pharma International Limited Nanoparticulate ebastine formulations
ES2277767B1 (es) * 2005-11-04 2008-04-01 Simbec Iberica, S.L. Formas orales solidas de ebastina.
JP2007297348A (ja) * 2006-05-02 2007-11-15 Daito Kk エバスチンを含有する錠剤
US8617597B2 (en) 2006-07-06 2013-12-31 Bayer Intellectual Property Gmbh Pharmaceutical composition containing a tetrahydrofolic acid
DE102008000351B4 (de) 2008-02-20 2017-08-10 Aristo Pharma Gmbh Verfahren zur Herstellung eines Ebastin enthaltenden Granulats sowie einer festen pharmazeutischen Zusammensetzung, Ebastin enthaltendes Granulat und dessen Verwendung
DE202011000756U1 (de) 2011-03-31 2011-10-12 Micro Labs Limited Ebastine, nicht-mikronisierte Ebastinepartikel und pharmazeutische Zusammensetzungen umfassend Ebastine
WO2013081562A1 (en) 2011-10-13 2013-06-06 Mahmut Bilgic Oral formulations comprising ebastine
WO2013062498A1 (en) * 2011-10-13 2013-05-02 Mahmut Bilgic Solid oral formulations comprising ebastine
EP2589376B1 (en) 2011-11-01 2016-09-21 Inopharm Limited Oral disintegrating composition of anti-histamine agents
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
CN105326802A (zh) * 2015-09-01 2016-02-17 杭州澳医保灵药业有限公司 一种依巴斯汀分散片及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8321157D0 (en) * 1983-08-05 1983-09-07 Fordonal Sa Piperidine derivatives
US4783465A (en) * 1984-04-09 1988-11-08 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US4871733A (en) * 1984-04-09 1989-10-03 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US4975426A (en) * 1987-06-08 1990-12-04 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US4829064A (en) * 1987-06-08 1989-05-09 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
DE3720493A1 (de) * 1987-06-20 1989-01-26 Nattermann A & Cie Arzneizubereitungen mit mikronisierten ebselen-kristallen
EP0402422A1 (en) * 1988-04-27 1990-12-19 Schering Corporation Certain paf antagonist antihistamine combinations and methods
JP2642486B2 (ja) * 1989-08-04 1997-08-20 田辺製薬株式会社 難溶性薬物の超微粒子化法
US5356887A (en) * 1990-01-31 1994-10-18 Merck & Co., Inc. Pharmaceutical compositions containing insoluble calcium salts of amino-hydroxybutylidene bisphoshonic acids
US5271944A (en) * 1991-04-05 1993-12-21 Biofor, Ltd. Pharmacologically enhanced formulations

Also Published As

Publication number Publication date
WO1993010782A1 (fr) 1993-06-10
DE69217554D1 (de) 1997-03-27
FR2684298B1 (fr) 1994-03-11
FR2684298A1 (fr) 1993-06-04
JP3518601B2 (ja) 2004-04-12
US5460829A (en) 1995-10-24
DK0614362T5 (da) 2008-11-10
EP0614362A1 (fr) 1994-09-14
GR3022615T3 (en) 1997-05-31
EP0614362B1 (fr) 1997-02-19
CA2123232A1 (fr) 1993-06-10
HK1006273A1 (en) 1999-02-19
JPH07501533A (ja) 1995-02-16
CA2123232C (fr) 2005-02-15
ATE148990T1 (de) 1997-03-15
ES2097490T3 (es) 1997-04-01
DE69217554T2 (de) 1997-08-07

Similar Documents

Publication Publication Date Title
DK0614362T3 (da) Farmaceutiske præparater på basis af ebastin og dermed analoge forbindelser
FI962324A (fi) N-substituoituja atsabisykloalkaanijohdannaisia neuroleptisinä aineina ASF
DK0711280T3 (da) Perhydroisoindolderivater, fremstilling af disse forbindelser og farmaceutiske præparater indeholdende disse forbindelser
PL314188A1 (en) Novel derivatives of benzoguanidine, method of obtaining them and their application in pharmaceutical compositions
IL114241A0 (en) Thiazolidine derivatives their preparation and compositions containing them
NO306345B1 (no) Piperidin-derivater med PAF antagonist-aktivitet, anvendelse derav og farmasöytisk blanding
DK0623121T3 (da) Fremstilling af N-acetylneuraminsyrederivater
AU644458B2 (en) Novel piperidyl ethers and thioethers as inhibitors of cholesterol biosynthesis
DK0450420T3 (da) Heterocyclisk substituerede dihydropyridiner, fremgangsmåde til deres fremstilling og deres anvendelse i lægemidler
IL117209A (en) 1-aryl-2-acylamino-ethane compounds and pharmaceutical compositions containing them
FI962323A0 (fi) N-substituoidut atsabisykloheptaanijohdannaiset, kuten esim. neuroleptit
DK0623138T3 (da) Nye adenosinderivater, fremgangsmåder til deres fremstilling og farmaceutiske præparater med indhold deraf
AU6415994A (en) Substituted caprolactams and derivatives thereof useful for treatment of hiv disease
DK0552765T3 (da) benzimidazoler, farmaceutiske præparater indeholdende disse og fremgangsmåde til deres fremstilling
DK0876393T3 (da) 21-(2-oxo-tetrahydrofuran)-thio-pregnanderivater, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indehold
EP0530016A3 (en) Piperidine derivative and pharmaceutical composition containing it